Akebia Therapeutics, Inc. (AKBA)
NASDAQ: AKBA · Real-Time Price · USD
1.140
+0.100 (9.62%)
At close: Jun 26, 2026, 4:00 PM EDT
1.138
-0.002 (-0.18%)
After-hours: Jun 26, 2026, 7:49 PM EDT
Akebia Therapeutics Employees
Akebia Therapeutics had 194 employees as of December 31, 2025. The number of employees increased by 13 or 7.18% compared to the previous year.
Employees
194
Change (1Y)
13
Growth (1Y)
7.18%
Revenue / Employee
$1,197,959
Profits / Employee
-$105,727
Market Cap
305.81M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Aurora Cannabis | 1,028 |
| Canopy Growth | 960 |
| Emergent BioSolutions | 900 |
| Organogenesis Holdings | 854 |
| Kamada | 462 |
| Lifecore Biomedical | 382 |
| Evolus | 350 |
| Anika Therapeutics | 235 |
AKBA News
- 10 days ago - Akebia Therapeutics Transcript: AGM 2026 - Transcripts
- 17 days ago - Akebia announces new Vafseo patent - TheFly
- 17 days ago - Akebia Therapeutics Strengthens Vafseo® (vadadustat) Patent Portfolio - GlobeNewsWire
- 23 days ago - Akebia Therapeutics Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 26 days ago - Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 4 weeks ago - Akebia Therapeutics to Present at the 2026 Jefferies Global Healthcare Conference - GlobeNewsWire
- 7 weeks ago - Akebia Therapeutics Earnings Call Transcript: Q1 2026 - Transcripts
- 7 weeks ago - Akebia Therapeutics Earnings release: Q1 2026 - Filings